Drug Information

Drug General Information
Drug ID
D0YV4F
Former ID
DCL000581
Drug Name
Ocrelizumab
Synonyms
Ocrelizumab (USAN); Ocrelizumab (genetical recombination); Ocrelizumab (genetical recombination) (JAN)
Drug Type
Antibody
Indication Relapsing or primary progressive forms of multiple sclerosis [ICD10:G35] Approved [889446]
Company
Genentech
CAS Number
CAS 637334-45-3
PubChem Substance ID
47206937
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info [536651], [551607]
KEGG Pathway Hematopoietic cell lineage
References
Ref 889446Drugs@FDA (Edaravone)
Ref 536651Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
Ref 551607Clinical pipeline report, company report or official report of Roche (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.